These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial. Furuta S; Sugiyama T; Umibe T; Kaneko Y; Amano K; Kurasawa K; Nakagomi D; Hiraguri M; Hanaoka H; Sato Y; Ikeda K; Nakajima H; BMJ Open; 2017 Dec; 7(12):e018748. PubMed ID: 29247107 [TBL] [Abstract][Full Text] [Related]
9. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab. Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574 [TBL] [Abstract][Full Text] [Related]
10. [Recommendations on the use of rituximab for ANCA-associated vasculitis]. Gause AM; Rubbert-Roth A; Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911 [TBL] [Abstract][Full Text] [Related]
11. Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial. Furuta S; Nakagomi D; Kobayashi Y; Hiraguri M; Sugiyama T; Amano K; Umibe T; Kono H; Kurasawa K; Kita Y; Matsumura R; Kaneko Y; Ninagawa K; Hiromura K; Kagami SI; Inaba Y; Hanaoka H; Ikeda K; Nakajima H; JAMA; 2021 Jun; 325(21):2178-2187. PubMed ID: 34061144 [TBL] [Abstract][Full Text] [Related]
12. Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial. Gopaluni S; Smith RM; Lewin M; McAlear CA; Mynard K; Jones RB; Specks U; Merkel PA; Jayne DR; Trials; 2017 Mar; 18(1):112. PubMed ID: 28270229 [TBL] [Abstract][Full Text] [Related]
13. Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Wallace ZS; Fu X; Liao K; Kallenberg CGM; Langford CA; Merkel PA; Monach P; Seo P; Specks U; Spiera R; St Clair EW; Zhang Y; Choi H; Stone JH Arthritis Rheumatol; 2019 Nov; 71(11):1879-1887. PubMed ID: 31162829 [TBL] [Abstract][Full Text] [Related]
14. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis. Pepper RJ; McAdoo SP; Moran SM; Kelly D; Scott J; Hamour S; Burns A; Griffith M; Galliford J; Levy JB; Cairns TD; Gopaluni S; Jones RB; Jayne D; Little MA; Pusey CD; Salama AD Rheumatology (Oxford); 2019 Feb; 58(2):260-268. PubMed ID: 30239910 [TBL] [Abstract][Full Text] [Related]
15. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis. Timlin H; Lee SM; Manno RL; Seo P; Geetha D Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088 [TBL] [Abstract][Full Text] [Related]
16. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Miloslavsky EM; Niles JL; Wallace ZS; Cortazar FB; Fernandes A; Laliberte K; Stone JH Semin Arthritis Rheum; 2018 Oct; 48(2):288-292. PubMed ID: 29530330 [TBL] [Abstract][Full Text] [Related]
18. Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report. Harris C; Marin J; Beaulieu MC BMC Nephrol; 2018 Jun; 19(1):152. PubMed ID: 29954345 [TBL] [Abstract][Full Text] [Related]
19. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. Monach PA; Tomasson G; Specks U; Stone JH; Cuthbertson D; Krischer J; Ding L; Fervenza FC; Fessler BJ; Hoffman GS; Ikle D; Kallenberg CG; Langford CA; Mueller M; Seo P; St Clair EW; Spiera R; Tchao N; Ytterberg SR; Gu YZ; Snyder RD; Merkel PA Arthritis Rheum; 2011 Dec; 63(12):3988-97. PubMed ID: 21953143 [TBL] [Abstract][Full Text] [Related]
20. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies. Ayan G; Esatoglu SN; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Fresko I; Ozdogan H; Yurdakul S; Hamuryudan V Rheumatol Int; 2018 Apr; 38(4):607-622. PubMed ID: 29322343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]